The efficacy of captopril and 5-fluorouracil combination in the proliferation and collagen deposition of keloid fibroblast

Keloid is a benign fibroproliferative tissue growth that exceeds the initial wound margins. Captopril has been tested in vitro to reduce fibroblast proliferation and collagen deposition; thus, it has potential for use in the treatment of keloids. Meanwhile, 5‐fluorouracil (5‐FU) has already been use...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Amelia, Jesslyn, Siswati, Agnes Sri, Wirohadidjojo, Yohanes Widodo
التنسيق: مقال
اللغة:English
منشور في: Universitas Gadjah Mada, Research Center for Biotechnology 2022
الموضوعات:
الوصول للمادة أونلاين:https://repository.ugm.ac.id/283312/1/document.pdf
_version_ 1826050624229212160
author Amelia, Jesslyn
Siswati, Agnes Sri
Wirohadidjojo, Yohanes Widodo
author_facet Amelia, Jesslyn
Siswati, Agnes Sri
Wirohadidjojo, Yohanes Widodo
author_sort Amelia, Jesslyn
collection UGM
description Keloid is a benign fibroproliferative tissue growth that exceeds the initial wound margins. Captopril has been tested in vitro to reduce fibroblast proliferation and collagen deposition; thus, it has potential for use in the treatment of keloids. Meanwhile, 5‐fluorouracil (5‐FU) has already been used in keloid management. This study aimed to determine the efficacy of the combination of captopril and 5‐FU in keloid fibroblast cultures. Keloid tissues were cultured up to passages 4–7. The study consisted of a control group, captopril in various concentrations (10‐2, 10‐3, 10‐4, and 10‐5 mol/L), 5‐FU 1 mg/mL and a combination of captopril at various concentrations with 5‐FU 1 mg/mL. After 144 hours of treatment, fibroblast proliferation and collagen deposition were measured. The study showed a significant decrease in the mean index of fibroblast proliferation and collagen deposition in the group receiving captopril in various concentrations (10‐2, 10‐3, 10‐4, and 10‐5 mol/L) and the 5‐FU group against the control group (p<0.05). In the combined‐dose group, captopril at a concentration of 10‐2 mol/L and 5‐FU showed a significant reduction in fibroblast proliferation and collagen deposition compared to the 5‐FU group and the captopril at the same dose (p<0.05). In conclusion, the combination of captopril 10‐2 mol/L and 5‐FU 1 mg/mL is better at reducing fibroblast proliferation and collagen deposition in keloid fibroblast cultures than captopril or 5‐FU as a single therapeutic agent.
first_indexed 2024-03-14T00:07:31Z
format Article
id oai:generic.eprints.org:283312
institution Universiti Gadjah Mada
language English
last_indexed 2024-03-14T00:07:31Z
publishDate 2022
publisher Universitas Gadjah Mada, Research Center for Biotechnology
record_format dspace
spelling oai:generic.eprints.org:2833122023-11-20T06:24:36Z https://repository.ugm.ac.id/283312/ The efficacy of captopril and 5-fluorouracil combination in the proliferation and collagen deposition of keloid fibroblast Amelia, Jesslyn Siswati, Agnes Sri Wirohadidjojo, Yohanes Widodo Dermatology Keloid is a benign fibroproliferative tissue growth that exceeds the initial wound margins. Captopril has been tested in vitro to reduce fibroblast proliferation and collagen deposition; thus, it has potential for use in the treatment of keloids. Meanwhile, 5‐fluorouracil (5‐FU) has already been used in keloid management. This study aimed to determine the efficacy of the combination of captopril and 5‐FU in keloid fibroblast cultures. Keloid tissues were cultured up to passages 4–7. The study consisted of a control group, captopril in various concentrations (10‐2, 10‐3, 10‐4, and 10‐5 mol/L), 5‐FU 1 mg/mL and a combination of captopril at various concentrations with 5‐FU 1 mg/mL. After 144 hours of treatment, fibroblast proliferation and collagen deposition were measured. The study showed a significant decrease in the mean index of fibroblast proliferation and collagen deposition in the group receiving captopril in various concentrations (10‐2, 10‐3, 10‐4, and 10‐5 mol/L) and the 5‐FU group against the control group (p<0.05). In the combined‐dose group, captopril at a concentration of 10‐2 mol/L and 5‐FU showed a significant reduction in fibroblast proliferation and collagen deposition compared to the 5‐FU group and the captopril at the same dose (p<0.05). In conclusion, the combination of captopril 10‐2 mol/L and 5‐FU 1 mg/mL is better at reducing fibroblast proliferation and collagen deposition in keloid fibroblast cultures than captopril or 5‐FU as a single therapeutic agent. Universitas Gadjah Mada, Research Center for Biotechnology 2022-09 Article PeerReviewed application/pdf en https://repository.ugm.ac.id/283312/1/document.pdf Amelia, Jesslyn and Siswati, Agnes Sri and Wirohadidjojo, Yohanes Widodo (2022) The efficacy of captopril and 5-fluorouracil combination in the proliferation and collagen deposition of keloid fibroblast. Indonesian Journal of Biotechnology, 27 (3). pp. 126-132. ISSN 2089-2241 https://journal.ugm.ac.id/ijbiotech/article/view/69505 10.22146/ijbiotech.69505
spellingShingle Dermatology
Amelia, Jesslyn
Siswati, Agnes Sri
Wirohadidjojo, Yohanes Widodo
The efficacy of captopril and 5-fluorouracil combination in the proliferation and collagen deposition of keloid fibroblast
title The efficacy of captopril and 5-fluorouracil combination in the proliferation and collagen deposition of keloid fibroblast
title_full The efficacy of captopril and 5-fluorouracil combination in the proliferation and collagen deposition of keloid fibroblast
title_fullStr The efficacy of captopril and 5-fluorouracil combination in the proliferation and collagen deposition of keloid fibroblast
title_full_unstemmed The efficacy of captopril and 5-fluorouracil combination in the proliferation and collagen deposition of keloid fibroblast
title_short The efficacy of captopril and 5-fluorouracil combination in the proliferation and collagen deposition of keloid fibroblast
title_sort efficacy of captopril and 5 fluorouracil combination in the proliferation and collagen deposition of keloid fibroblast
topic Dermatology
url https://repository.ugm.ac.id/283312/1/document.pdf
work_keys_str_mv AT ameliajesslyn theefficacyofcaptopriland5fluorouracilcombinationintheproliferationandcollagendepositionofkeloidfibroblast
AT siswatiagnessri theefficacyofcaptopriland5fluorouracilcombinationintheproliferationandcollagendepositionofkeloidfibroblast
AT wirohadidjojoyohaneswidodo theefficacyofcaptopriland5fluorouracilcombinationintheproliferationandcollagendepositionofkeloidfibroblast
AT ameliajesslyn efficacyofcaptopriland5fluorouracilcombinationintheproliferationandcollagendepositionofkeloidfibroblast
AT siswatiagnessri efficacyofcaptopriland5fluorouracilcombinationintheproliferationandcollagendepositionofkeloidfibroblast
AT wirohadidjojoyohaneswidodo efficacyofcaptopriland5fluorouracilcombinationintheproliferationandcollagendepositionofkeloidfibroblast